SERZONE

Serzone is an anti-depressant medication that is often used to treat a specific form of depression. This medication has been linked to liver failure. People that take Serzone may have a higher risk (3-4 times) of having liver failure than people that don't take Serzone. Bristol-Myers Squibb Co., the manufacturer of Serzone, released a warning on January 9, 2002, telling health care providers that "cases of life-threatening hepatic failure have been reported in patients treated with Serzone".
The warning suggests that numerous patients have experienced or will suffer liver failure. U.S. doctors first became aware about the potential of Serzone to cause liver failure after the Canadian government issued a warning about the drug in the summer of 2001.